Skip to content

Exploring the Future of Inhalation Drug Delivery

The Gilbert team looks forward to attending the International Conference on “Exploring the Future of Inhalation Drug Delivery“, organized by the University of Parma and supported by the Galenus Foundation, in Parma, Italy from Sept 11th-13th.

As we are working hard on the development of our Smart Precision Inhaler, we look forward to connecting with professionals working on improvements in formulation and development of inhaled medicine.

With customizable aerosol generation, we believe that Gilbert’s electrospray soft mist inhaler may hold significant promise for the delivery of the innovative medicines under research today.

Let’s redefine treatment for lung patients together!

So if you are also visiting, let’s meet up in Parma!

To plan a meeting, please contact us at info@Gilbert.eu or reach out directly to our team members Mehmet Uzumcu, Scott Fleming or Fatemeh Jahanmard who will be visiting the conference.

 

Gilbert is developing the next generation of soft mist inhalers based on a proprietary electrospray (Electro Hydrodynamic Atomization or EHDA) technology to redefine treatment for lung patients. Gilbert’s breath actuated smart precision inhaler creates a monodispersed soft mist aerosol, with a customizable droplet size enabling more precise targeting of drugs to desired regions of the lungs, which has the potential to improve the efficacy and safety of treatments. Electrospray enables gentle, efficient delivery of both small and large molecule therapies in both solution and suspension formulations.

Visit us at Gilbert | Redefining treatment for lung patients, follow us on Linkedin or contact us at info@gilbert.eu to learn if electrospray is suitable for your application.

Other posts

Let’s stay in touch!

Stay up-to-date with Gilbert’s latest news, vacancies and achievements by following us on social media.